![Markus Gemuend](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Markus Gemuend
Plus aucun poste en cours
Profil
Markus Gemuend served as the Chief Executive Officer of Lonza Group AG from 2002 to 2004.
He also worked as the Senior Vice President at Lonza Biologics Plc.
In 2012, he held the position of SVP & Head-Procurement Development Regulations at Genentech, Inc. Mr. Gemuend obtained an undergraduate degree from the University of Basel.
Anciens postes connus de Markus Gemuend
Sociétés | Poste | Fin |
---|---|---|
LONZA GROUP AG | Directeur Général | 01/06/2004 |
Lonza Biologics Plc
![]() Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Corporate Officer/Principal | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Conseiller Juridique Général | 29/08/2012 |
Formation de Markus Gemuend
University of Basel | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
LONZA GROUP AG | Health Technology |
Entreprise privées | 2 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Lonza Biologics Plc
![]() Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Commercial Services |